DIN 02522845 — SAPHNELO 150 MG
SAPHNELO is a solution of Anifrolumab marketed by ASTRAZENECA CANADA INC. The full Anifrolumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02522845
- Brand name
- SAPHNELO
- Active ingredient
- Anifrolumab
- Strength
- 150 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Type I interferon receptor antagonist (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Anifrolumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02566338 | SAPHNELO | 120 MG | SOLUTION | ASTRAZENECA CANADA INC | MARKETED |